Core Viewpoint - Univest Securities, LLC has successfully closed a public offering of approximately $15 million for Globavend Holdings Limited, an emerging e-commerce logistics provider [1][4]. Group 1: Offering Details - The offering consists of 21,739,130 ordinary shares or pre-funded warrants, each sold with one Series A Warrant at an initial exercise price of $0.69 and one Series B Warrant at an initial exercise price of $1.173 [2]. - The purchase price for each ordinary share and accompanying warrants is $0.69, while the pre-funded warrants are priced at $0.689 [3]. - The gross proceeds to Globavend from this offering are approximately $15 million before deducting fees and expenses [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for capital expenditures, increasing operating capacity, working capital, general corporate purposes, purchasing warehouses, and potential mergers and acquisitions [4]. Group 3: Company Overview - Globavend Holdings Limited provides end-to-end logistics solutions primarily for enterprise customers in Hong Kong, Australia, and New Zealand, facilitating B2C transactions [9]. - The company offers integrated cross-border logistics services, including parcel drop-off, consolidation, air-freight forwarding, customs clearance, and final delivery [9].

Core Viewpoint - Nuwellis, Inc. has successfully closed a public offering, raising approximately $5.0 million through the sale of common stock and warrants, aimed at transforming care for fluid overload patients [1][2]. Summary by Sections Public Offering Details - The offering included 2,580,667 shares of common stock and pre-funded warrants to purchase 14,085,998 shares, along with Series A and Series B Warrants [1]. - The public offering price was set at $0.30 per share and accompanying warrants, while the pre-funded warrants were priced at $0.2999 [2]. Warrant Specifications - Pre-funded warrants have an exercise price of $0.0001 and are immediately exercisable until fully exercised [3]. - Series A and Series B Warrants have an exercise price of $0.30 and will be exercisable for five years post stockholder approval [3]. - Series A Warrants include a one-time reset of the exercise price in case of a reverse stock split, while Series B Warrants offer a zero cash exercise option [3]. Underwriter Information - Ladenburg Thalmann & Co. Inc. served as the sole book-running manager for the offering [4]. Regulatory Compliance - The securities are offered under a registration statement on Form S-1, which was declared effective by the SEC on June 9, 2025 [5].